TVARDI THERAPEUTICS, INC. Operating Lease, Liability, Current
TVARDI THERAPEUTICS, INC. (TVRD) had Operating Lease, Liability, Current of $123.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-14
- 2026-06-30: Operating Lease, Liability, Current $123.00K.
- 2026-03-31: Operating Lease, Liability, Current $120.00K.
- 2025-12-31: Operating Lease, Liability, Current $116.00K.
- 2025-09-30: Operating Lease, Liability, Current $113.00K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $123.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $120.00K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $116.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $113.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $109.00K 10-Q · filed 2025-08-14 |
| 2024-12-31 | $103.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $3.42M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $168.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $220.00K 10-Q · filed 2024-05-13 |
| 2023-09-30 | $497.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $982.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $1.46M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.92M 10-K · filed 2024-03-06 |
| 2022-09-30 | $1.88M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $1.83M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $1.79M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $1.75M 10-K · filed 2023-03-06 |
| 2021-09-30 | $1.72M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $1.68M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $1.64M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $1.60M 10-K · filed 2022-03-01 |
| 2020-09-30 | $1.03M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.01M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $991.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $967.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $945.00K 10-Q · filed 2019-11-05 |
| 2019-06-30 | $923.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $901.00K 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |